MSCs "Versus" Or MSCs "Via" T Cells For Cell & Gene Therapy?
By Jonathan Carson, RoosterBio
To many biologists and immunologists, the notion that T cells and mesenchymal stromal/stem cells (MSCs) can be compared in the same “ice bucket” sounds, at best, simplistic. Nevertheless, both cell types are indeed routinely measured against each other by regenerative medicine product developers as they “whiteboard” their early concepts and TPPs. As the basis for emerging technology and therapeutic platforms, these two distinct lineages each have unique talents that can be aimed at both overlapping and discrete unmet medical needs. Even more fascinating is how T cells and MSCs don’t have to compete for program time and resources—but can instead work together quite nicely!
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.